Telomeres and chromosomal instability in chronic lymphocytic leukemia
Leukemia (2013) 27, 490-493; doi:10.1038/leu. 2012.194 Telomeres are protective chromosomal end structures composed of G-rich nucleotide repeats and an associated protein complex termed shelterin. Because of incomplete replication, telomeric repeats are lost with every cell division, and this telomere attrition is involved in cell senescence and cancer (reviewed in Artandi and DePinho 1 ). Short, unprotected telomeres are erroneously fused by the DNA-repair system, which gives rise to aneuploidies or structural chromosome rearrangements through chromosome fusion-bridge-breakage cycles. Thus, telomere dysfunction can drive genomic instability during tumorigenesis. 1 In chronic lymphocytic leukemia (CLL), short telomeres have been associated with poor-prognosis cytogenetics. 2, 3 Besides telomere length, the functional state of telomeres depends on several molecular factors. Telomeres can be regenerated by telomerase and are protected from fusions by shelterin proteins. Detailed investigations assessing all together the expression of telomerase and shelterin genes, telomere length, recurrent aberrations and overall karyotype instability have not yet been reported in CLL. Here, we studied the telomere status and chromosomal aberrations in a series of CLL patients. A clustering analysis of the data identified groups with distinct cytogenetic and telomere profiles.
This prospective study included 77 patients (57 males and 20 females, median age of 67 years) diagnosed with CLL at the Clermont-Ferrand University Hospital. Blood samples were obtained after informed consent. At the time of sampling, 34 patients were in Binet stage A, 17 in stage B and 26 in stage C. Samples were obtained before any treatment in 60 (77.9%) patients. Among the remaining 17 cases, 16 received no treatment within 6 months prior to the date of sampling.
Karyotype was analyzed after immunostimulation of cell cultures with the CpG-oligonucleotide DSP30 and interleukin 2. Interphase fluorescence in situ hybridization (FISH) was performed with a panel of commercially available probes (Abbott Molecular, Rungis, France) for the detection of trisomy 12 and deletions of 13q14, 11q22.3 (ATM) and 17p13 (p53).
Telomere studies were performed on mononuclear cells (MNCs). Average telomere length was evaluated with quantitative realtime DNA PCR. 2 The method measures the difference between a sample and a reference normal DNA in the ratio of telomere repeat copy number to single-gene copy number (relative T/S ratio). This T/S ratio is proportional to the average telomere length assessed with a classical telomere restriction fragment analysis (r ¼ 0.89; Supplementary Figure S1 ). Letters to the editor The expression of hTERT (human telomerase reverse transcriptase) and core members of the shelterin complex, TRF1 and TRF2 (telomeric repeat binding factors 1 and 2) and POT1 (protection of telomeres 1) genes were quantified using real-time quantitative PCR. 4, 5 The normalized copy numbers (NCNs) were expressed as the ratio between transcript copy numbers of the target and control (GUS) genes multiplied by 100. Letters to the editor after selection of CD19 þ cells. The mean values of CD19 þ cells were 75.6 ± 13.9% before and 98.2 ± 2.4% after selection. We did not find any statistically significant difference between the values of telomere length and gene expression obtained before and after selection (data not shown). Unsupervised hierarchical clustering analyses on the basis of either a combination of cytogenetic and telomeric characteristics or cytogenetic and telomeric parameters alone were performed to identify subclasses with distinct chromosome aberration and telomeric profiles (Figures 1a-c) . Karyotype and FISH data were qualitative. Karyotypes were characterized by the presence or absence of aneuploidies, translocations or deletions. FISH patterns were as follows: normal, del(13q), trisomy 12, del(17p) or del(11q). Single FISH aberrations were found in 48 cases and multiple aberrations in 10 cases. In nine cases, deletions of 17p or 11q were accompanied either by a del(13q) or a trisomy 12. One case showed the presence of a trisomy 12 and a del(13q). Telomere characteristics were included as quantitative values: relative T/S ratios for telomere length and NCN of hTERT, TRF1, TRF2 and POT1 transcripts. The differences in the incidence of chromosomal aberrations and in the values of telomere parameters across the clusters were analyzed statistically ( Table 1) .
Clustering of the combined data set highlighted three groups. Cluster I demonstrated good-prognosis cytogenetics (isolated del(13q) or normal cytogenetics), long telomeres, negative or low hTERT and a high expression of the shelterin complex genes (TRF1, TRF2 and POT1 values were similar to those of normal B cells, data not shown). In contrast, clusters II and III displayed multiple chromosome aberrations, mostly aneuploidies in cluster II and structural chromosomal changes in cluster III. All poor-prognosis del(17p) and del(11q) cases were in cluster III, which also showed multiple karyotypic abnormalities (50% of cases) and translocations (72% of cases), the majority of translocations (86%) being unbalanced. Clusters II and III were characterized by a striking decrease in telomere length and shelterin gene-expression levels. Thus, rising chromosomal instability was associated with telomeric deficiency. The hTERT gene was activated in clusters II and III, consistently with its role in stabilization of rearranged tumor genomes. 1 The results also highlight the relationship of 17p and 11q deletions with more sever telomere and chromosome instability. These deletions lead to the loss of p53 and ATM genes, respectively, which are involved in monitoring telomere and DNA integrity. An impact of p53 and ATM deficiency on telomere length was previously reported in CLL cells. 2, 6 Separate clustering of cytogenetic (Figure 1b ) and telomeric data (Figure 1c ) also showed the relationship between the telomere status and chromosomal aberrations. In particular, cytogenetic cluster 1 without any chromosomal aberration was normal in terms of telomere characteristics (Table 1) . Cytogenetic cluster 2 displays structural chromosomal changes, including 17p or 11q deletions, and telomere shortening, high hTERT and decreased shelterin gene-expression levels. Clustering of telomere parameters alone revealed an interesting group (cluster 3*) with deficient telomeres with the highest hTERT level, presenting high incidences of various aberrations, such as aneuploidies (52%), translocations or deletions (79%), del(17p) and del(11q) (55%) and a trisomy 12 (24%). Unlike telomere length, the level of shelterin complex genes in CLL was not previously analyzed in relation to chromosomal instability. The total expression of shelterin genes was found to be lower in clusters harboring an increased rate of aberrations (clusters III, 2 and 3*, Table 1 ). This reduced expression was also associated with shorter telomere length. Shelterin downregulation may either be secondary to telomere shortening or, in contrast, may drive telomere dysfunction, thus compromising chromosomal integrity. 7 The present data do not allow us to examine this issue, although some evidence exists. In particular, cluster 1* characterized by long telomeres and low level of chromosome aberrations contains a small subcluster with significantly decreased shelterin gene expression (seven last patients of cluster 1*, Figure 1 ). Interestingly, this subcluster did not harbor more chromosome aberrations than the second subcluster (first 15 patients) characterized by higher shelterin levels (data not shown). Given the small patient number, this result should be taken with caution, but it suggests that the shelterin reduction may be insufficient for the acquisition of substantial chromosomal instability when telomeres are (still) long. Follow-up studies in such patients could help to investigate if a sustained shelterin downregulation would lead to more rapid telomere erosion and/ or accumulation of aberrations. In addition, interactions with other shelterin complex members could have a role in chromosomal instability. Studies of RAP1, TPP1 and TIN2 gene expression are needed to clarify the involvement of shelterin alterations in chromosomal instability in CLL.
We also evaluated well-established factors predictive of CLL progression in patients from different clusters to determine if the Telomere length (T/S ratio)
1.6 ± 0.1 0.9 ± 0.1 0.6 ± 0.1 o10
9.0±4.8 9.7±5.8 118±16 o10
TRF1 (NCN) 145 ± 9 9 7 ± 9 8 4 ± 9 o10 À 3 142 ± 10 83 ± 8 1 3 0 ± 10 o10 
Letters to the editor obtained classification may be clinically significant. Figure 1d shows the incidence of negative prognostic features, such as Binet C stage, unmutated (UM) immunoglobulin variable region genes (IgVH), CD38 positivity (X30%) and short (o6 months) lymphocyte doubling time (LDT), in different clusters. No significant relationship was found with Binet C stage. In contrast, clusters with enhanced telomere and chromosome instability showed higher incidences of classical biological factors of poor prognosis. Of note, the strongest associations with UM IgVH and CD38 positivity were found for clusters obtained by combining telomeric and cytogenetic parameters, whereas the links with telomeric clusters were weaker but still significant and, finally, the associations with cytogenetic clusters were not significant. Only the combined model showed a significant relationship with short LDT. Cytogenetics and telomeres are known to represent valuable prognostic factors in CLL, 2 and perhaps the combinations of both characteristics could provide a more accurate prediction of disease progression. Our study was prospective, and so far we were not able to compare survival of patients from different clusters. This issue can be addressed in a large cohort of CLL patients with adequate follow-up.
In conclusion, the identification of groups with distinct telomeric and cytogenetic profiles supports the link between telomere status and genomic instability in CLL. Telomere shortening, changes in shelterin and hTERT gene expression coincided with increasing levels of chromosome aberrations, and this was particularly affected by p53 or ATM gene deletions. Theses CLL groups are associated with established prognostic factors and may be clinically significant.
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu) Partial 17q gain resulting from isochromosomes, unbalanced translocations and complex rearrangements is associated with gene overexpression, older age and shorter overall survival in high hyperdiploid childhood acute lymphoblastic leukemia High hyperdiploid acute lymphoblastic leukemia (ALL) is associated with a B-cell precursor (BCP) immunophenotype, low white blood cell count, age between 3 and 5 years, and a favorable prognosis. 1 It is characterized by 51-67 chromosomes, with nonrandom trisomies and tetrasomies. Interestingly, partial gains of the common extra chromosomes are rare, 1 with the exception of chromosome 17, which is trisomic in 75% of cases and forms an isochromosome resulting in 17q gain and 17p loss in an additional 2-5% of cases. 2, 3 We recently reported that partial gains of 17q is present in 9% of high hyperdiploid ALL as detected by singlenucleotide polymorphism (SNP) array analysis. 4 Surprisingly, the majority of these 17q gains did not seem to arise from i(17q). We have now further characterized rearrangements with breakpoints in chromosome 17, screened for TP53 mutations, and investigated the gene expression in high hyperdiploid pediatric BCP ALL (Table 1; Supplementary Table 2) . Cases were included if they had uniparental disomy (UPD) or trisomy (UPT) involving 17p, had a 17p deletion, or gain of 17q not associated with trisomy 17, as ascertained by SNP array analysis. For cases 1-11, which were included in a series of 74 high hyperdiploid patients, 4 SNP array results have been previously published. Diagnostic bone
